Publication - Summary
Jan 19, 2016
Proceedings of the National Academy of Sciences
Liver cancer is a deadly disease with limited intervention options. Tumour removal surgery and liver transplantation are extremely complicated and not always possible. Several small molecule drugs aimed to treat hepatocellular carcinoma (HCC) have ...